Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




A Novel Nanowell Array Sensor for POC Measurement of Stress Hormones

By LabMedica International staff writers
Posted on 13 Jul 2021
Researchers have constructed a microchip "nanosensor" to measure stress hormones such as cortisol in a dedicated nanowell array, which does not require molecular labels or washing steps.

Investigators at Rutgers University (New Brunswick, NJ, USA) designed a nanowell device based on two electrode probes, which were integrated within the nanowell structure. The electrodes were stacked vertically above one another to minimize the electrode spacing. The electrodes were separated by a 40-nanometer insulator layer within the nanowells, meaning that the counter electrodes were actually integrated into the nanowell structure. This sensor geometry limited the exposed surface area of the electrodes, and, as a result, the amount of probe antibody molecules inside the nanowells, while also enhancing the sensitivity by focusing the electric field into the nanowells.

This functional geometry permitted rapid and low volume (less than five microliters) sensing through activation of the wells with antibodies and monitoring of real-time binding events. A 28-well plate biochip was built on a glass substrate by sequential deposition, patterning, and etching steps to create a stacked nanowell array sensor with an electrode gap of 40 nanometers. Sensor response for cortisol concentrations between one and 15 micrograms per deciliter in buffer solution was recorded, and a limit of detection of 0.5 micrograms per deciliter was achieved.

The nanowell array sensor was used to analyze 65 serum samples from patients with rheumatoid arthritis, and the results were compared to those obtained from the standard enzyme-linked immunosorbent assay (ELISA). The results confirmed that nanowell array sensors could be a promising platform for point-of-care testing, where real-time, laboratory-quality diagnostic results are essential.

"The use of nanosensors allowed us to detect cortisol molecules directly without the need for any other molecules or particles to act as labels," said first author Dr. Reza Mahmoodi, a postdoctoral researcher at Rutgers University. "Our new sensor produces an accurate and reliable response that allows a continuous readout of cortisol levels for real-time analysis. It has great potential to be adapted to non-invasive cortisol measurement in other fluids such as saliva and urine. The fact that molecular labels are not required eliminates the need for large bulky instruments like optical microscopes and plate readers, making the readout instrumentation something you can measure ultimately in a small pocket-sized box or even fit onto a wristband one day."

The nanowell array sensor was described in the June 30, 2021, online edition of the journal Science Advances.

Related Links:
Rutgers University


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.